NCT06904170
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06904170
Title Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma (ALICE)
Acronym ALICE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNICANCER
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU de Bordeaux NOT_YET_RECRUITING Bordeaux 33604 France Details
AP-HP Hôpital Beaujon RECRUITING Clichy 92110 France Details
Centre Georges Francois Leclerc NOT_YET_RECRUITING Dijon 21079 France Details
Hôpital Saint Joseph RECRUITING Marseille France Details
CHU de Montpellier NOT_YET_RECRUITING Montpellier 34295 France Details
CHU Hôtel-Dieu NOT_YET_RECRUITING Nantes 44093 France Details
AP-HP Hôpital Cochin RECRUITING Paris 75014 France Details
CHU de Poitiers NOT_YET_RECRUITING Poitiers 86000 France Details
Centre Eugene Marquis RECRUITING Rennes 35042 France Details
CHRU de Strasbourg NOT_YET_RECRUITING Strasbourg 67091 France Details
CHU de Rangueil RECRUITING Toulouse 31400 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field